Evotec SE was established on December 8, 1993 under the laws of Germany. The company is a leading drug discovery and development partner in the pharmaceutical and biotechnology industries. The company's mission is to collaborate with its partners to discover the best and best-in-class medicines for a variety of difficult-to-treat diseases. To this end, they have built a fully integrated next-generation technology platform that they believe will change the way new drugs are discovered. By leveraging the advanced capabilities of their integrated platform, they are able to provide partners with solutions that significantly improve the quality of new drugs while accelerating the drug discovery process and reducing the high consumption costs often associated with the traditional drug discovery process.